Trial · NCT05993299
Adverse events80
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 80
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Cytokine release syndrome | Immune system disorders | Letetresgene Autoleucel (Lete-cel) | 4 | 7 | 4 |
| other | Graft versus host disease | Immune system disorders | Letetresgene Autoleucel (Lete-cel) | 1 | 7 | 2 |
| other | COVID-19 | Infections and infestations | Letetresgene Autoleucel (Lete-cel) | 3 | 7 | 3 |
| other | Cytomegalovirus infection reactivation | Infections and infestations | Letetresgene Autoleucel (Lete-cel) | 1 | 7 | 1 |
| other | Enterocolitis infectious | Infections and infestations | Letetresgene Autoleucel (Lete-cel) | 1 | 7 | 1 |
| other | Pneumonia | Infections and infestations | Letetresgene Autoleucel (Lete-cel) | 1 | 7 | 1 |
| other | Rhinitis | Infections and infestations | Letetresgene Autoleucel (Lete-cel) | 1 | 7 | 2 |
| other | Alanine aminotransferase increased | Investigations | Letetresgene Autoleucel (Lete-cel) | 3 | 7 | 3 |
| other | Aspartate aminotransferase increased | Investigations | Letetresgene Autoleucel (Lete-cel) | 2 | 7 | 2 |
| other | Blood fibrinogen decreased | Investigations | Letetresgene Autoleucel (Lete-cel) | 2 | 7 | 3 |
| other | Neutrophil count decreased | Investigations | Letetresgene Autoleucel (Lete-cel) | 2 | 7 | 5 |
| other | Platelet count decreased | Investigations | Letetresgene Autoleucel (Lete-cel) | 2 | 7 | 2 |
| other | White blood cell count decreased | Investigations | Letetresgene Autoleucel (Lete-cel) | 2 | 7 | 2 |
| other | Blood alkaline phosphatase increased | Investigations | Letetresgene Autoleucel (Lete-cel) | 1 | 7 | 1 |
| other | Blood lactate dehydrogenase increased | Investigations | Letetresgene Autoleucel (Lete-cel) | 1 | 7 | 1 |
| other | Lymphocyte count decreased | Investigations | Letetresgene Autoleucel (Lete-cel) | 1 | 7 | 1 |
| other | Weight decreased | Investigations | Letetresgene Autoleucel (Lete-cel) | 1 | 7 | 1 |
| other | Constipation | Gastrointestinal disorders | Letetresgene Autoleucel (Lete-cel) | 3 | 7 | 4 |
| other | Gastrooesophageal reflux disease | Gastrointestinal disorders | Letetresgene Autoleucel (Lete-cel) | 3 | 7 | 3 |
| other | Nausea | Gastrointestinal disorders | Letetresgene Autoleucel (Lete-cel) | 3 | 7 | 6 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05993299/events